NVO · NYSE · Healthcare · Drug Manufacturers - General

Novo Nordisk

近一月
價格暫不可用
  • 52週區間35.12–64.16
  • 本益比11.28
  • 市值2013.07億

最新消息

載入中...

簡介

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovasc...

novonordisk.com